Philips, GE look to Saudi Arabian healthcare market; Navidea tries again for FDA approval;

 @FierceMedDev: Boston Sci snagged EU approval for its new stent with bioabsorbable coating. News | Follow @FierceMedDev

 @MarkHFierce: Fidelity is investing $75M into Trivitron Healthcare, an Indian company focused on imaging and lab Dx. Release | Follow @MarkHFierce

 @DamianFierce: The latest Cleveland Clinic top 10 innovations list includes some novel medical devices. Article | Follow @DamianFierce

> Cardiovascular Systems ($CSII) say its fiscal 2013 revenue hit $23.5 million, a 25% jump fueled by sales of it lead medical device to treat peripheral artery disease. Net losses reached $5.2 million, up from a $3.9 million net loss over the same period last year, driven by higher clinical trial and marketing spending. Release

> Philips and General Electric are among medical device or medical equipment companies investing in Saudi Arabia, Bloomberg reports. They anticipate major growth there, with health spending poised to reach $20 billion by 2016 as diabetes, heart disease and cancer rates soar. Story

> On the rebound from an earlier rejection, Navidea Biopharmaceuticals is re-filing its FDA application for Lymphoseek, a cancer diagnostic tool. News

> Thermedical gained 510(k) clearance in the U.S. to start marketing new technology that enables coagulation and ablation of soft tissue during percutaneous, laparoscopic and intraoperative surgical procedures. Item

> Chinese medical device giant Mindray Medical ($MR) will take part in MEDICA 2012, a global medical trade fair planned from Nov. 14-17 in Dusseldorf, Germany. Release

> CE mark in hand, Blue Medical is launching its Protégé NC drug-eluting balloon around the world. Release

> Beijing's Dehaier Medical inked a $1 million contract to provide medical devices to China's XinJiang Province. More

Biotech News

 @FierceBiotech: Ipsen braces for $153M write-off as troubled biotech partner declares bankruptcy. News | Follow @FierceBiotech

 @JohnCFierce: Biocon (India) scouts R&D pact after GE unit grabs stake in research division. Story | Follow @JohnCFierce

 @RyanMFierce: Biotech's boneyard: 2012 report on the dead, dying, disabled (and some reborn) biotech operations. Happy Halloween! Special Report | Follow @RyanMFierce

> Researchers nab $11M to fund second look at AstraZeneca's stockpile of failed drugs. Article

> Biogen streak lives on with upbeat PhIII results for hemophilia A therapy. Story

Pharma News

@FiercePharma: BMJ says no more clinical trial publications if actual data isn't open for outside review. More | Follow @FiercePharma

> Novo hikes forecast on 62% jump in Victoza sales. News

> BMJ editor flogs Roche for Tamiflu data secrecy. Story

> Novartis building new plant as pipeline fills with biologics. Article

Drug Delivery News

> Twice-yearly opioid dependence implant steps closer to the market. Item

> Ocular Therapeutix eyes up positive results for OTX-TP2. Article

> Starpharma technology delivers 40-fold more docetaxel to tumor. Report

> Paclitaxel particles extend life threefold in mouse bladder cancer. News

Biomarkers News

> Seeing is believing: Biomarkers visible to the naked eye. Item

> Blood biomarker tags NeuVax's role in breast cancer treatment. Article

> Marking glimpses of activity for Lilly's Alzheimer drug after PhIII struggles. Report

> U.K. researchers spot new marker for prostate cancer prognosis. News

> Chromosome cap length predicts pancreatic cancer risk. Story